REPOST: FENBENDAZOLE and CANCER – at least 12 Anti-Cancer mechanisms of action. Not approved by FDA. Cheap. Safe. Kills aggressive cancers. Why no Clinical Trials? Nine research papers reviewed

READ MORE….

Papers and Articles Reviewed:

• 2023 Jun – Movahedi et al – Repurposing anti-parasite benzimidazole drugs as selective anti-cancer chemotherapeutics
• 2023 Apr – Chi-Son Chang et al – Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer
• 2023 Mar – Semkova et al – Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
• 2023 Mar – Haebeen Jung et al – Differential cytotoxic effects of fenbendazole on mouse lymphoma EL-4 cells and spleen cells
• 2022 Sep – Deokbae Park et al – Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
• 2022 Jan – Li-wen Ren et al – Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
• 2020 Aug – Deok-Soo Son et al – The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
• 2020 Jun – Yong Han et al – Involvement of reactive oxygen species in the anti-cancer activity of fenbendazole, a benzimidazole anthelmintic (leukemia)
• 2018 Aug – Dogra et al – Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways